| Abstract |
Objective To study the clinical effects of music relaxation therapy combined with agomelatine in the treatment of postpartum depression. Methods A total of 68 postpartum depression patients admitted to our hospital from July 2016 to March 2019 were randomly divided into two groups, 34 in each group. The control group was treated with agomelatine, and the observation group was treated with music relaxation therapy. The two groups were compared with the Edinburgh Postnatal Depression Scale Score (EPDS), the Interpersonal Questionnaire Questionnaire (IIP-32), and the Couples Adaptation Scale (DAS). Mental Resilience Scale (CD-RISC), Clinical Efficacy Assessment Scale - Disease Severity Score (CGI-SI), Adverse Reactions. Results The EPDS scores of the observation group were lower than those of the control group 1, 2, 3 and 4 weeks after treatment (P<0.05). After 4 weeks of treatment, the IIP-32 score of the observation group was lower than that of the control group, and the DAS score was higher than that of the control group (P<0.05). After 4 weeks of treatment, the CGI-SI score of the observation group was lower than that of the control group, and the CD-RISC score was higher than that of the control group (P<0.05). The incidence of adverse reactions was compared between the two groups (2.94% vs 8.82%). The difference was not statistically significant. Meaning (χ2=0.266, P=0.606). Conclusion Music relaxation therapy combined with agomelatine in the treatment of postpartum depression can improve the relationship between husband and wife, improve the interpersonal ability and psychological flexibility of patients, reduce the patients condition, improve the patients depressive symptoms, and have high safety.
|